Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Nature Reviews. Clinical Oncology|September 21, 2018
Roles of the RANKL-RANK axis in antitumour immunity - implications for therapyElizabeth Ahern, Mark J Smyth, William C Dougall, et al.
The Journal of Clinical Investigation|August 5, 2015
From mice to humans: developments in cancer immunoeditingMichele W L Teng, Jerome Galon, Wolf-Herman Fridman, et al.
Current Topics in Microbiology and Immunology|June 1, 2010
Biology and clinical observations of regulatory T cells in cancer immunologyMichele W L Teng, David S Ritchie, Paul Neeson, et al.
Nature Reviews. Immunology|December 3, 2005
Supernatural T cells: genetic modification of T cells for cancer therapyMichael H Kershaw, Michele W L Teng, Mark J Smyth, et al.
Carbohydrate Research|May 30, 2001
Concurrent production of chitin from shrimp shells and fungiW L Teng, E Khor, T K Tan, et al.
The Lancet. Oncology|December 7, 2017
De-novo and acquired resistance to immune checkpoint targetingNicholas L Syn, Michele W L Teng, Tony S K Mok, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2009
CD1d activation and blockade: a new antitumor strategyMichele W L Teng, Simon Yue, Janelle Sharkey, et al.
Cancer Research|February 2, 2011
Anti-IL-23 monoclonal antibody synergizes in combination with targeted therapies or IL-2 to suppress tumor growth and metastasesMichele W L Teng, Bianca von Scheidt, Helene Duret, et al.
Human Gene Therapy|July 10, 2004
Immunotherapy of cancer using systemically delivered gene-modified human T lymphocytesMichele W L Teng, Michael H Kershaw, Maria Moeller, et al.
Oncoimmunology|March 26, 2013
The interaction between murine melanoma and the immune system reveals that prolonged responses predispose for autoimmunityShin Foong Ngiow, Bianca von Scheidt, Andreas Möller, et al.
Pageof 11